Your browser doesn't support javascript.
loading
Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
Xu, Yuan-Ji; Zhou, Rui; Zong, Jing-Feng; Lin, Wan-Song; Tong, Shuang; Guo, Qiao-Juan; Lin, Cheng; Lin, Shao-Jun; Chen, Yi-Xin; Chen, Mei-Ru; Chen, Hong-Lin; Ye, Yun-Bin; Pan, Jian-Ji.
Afiliação
  • Xu YJ; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zhou R; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zong JF; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Lin WS; Laboratory of Immune Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, China.
  • Tong S; State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Guo QJ; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, China.
  • Lin C; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Lin SJ; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, China.
  • Chen YX; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
  • Chen MR; Graduate Institute and Department of Microbiology, College of Medicine, National Taiwan University, Taiwan.
  • Chen HL; State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Ye YB; Laboratory of Immune Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, China. Electronic address: zjyunbin@189.cn.
  • Pan JJ; Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, China. Electronic address: panjianji@aliyun.com.
Cancer Lett ; 447: 33-40, 2019 04 10.
Article em En | MEDLINE | ID: mdl-30684592
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Viral / Transdução de Sinais / Herpesvirus Humano 4 / MicroRNAs / Proliferação de Células / Carcinoma Nasofaríngeo / Metástase Neoplásica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Viral / Transdução de Sinais / Herpesvirus Humano 4 / MicroRNAs / Proliferação de Células / Carcinoma Nasofaríngeo / Metástase Neoplásica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article